Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS.

Source:http://linkedlifedata.com/resource/pubmed/id/19805378

Proc. Natl. Acad. Sci. U.S.A. 2009 Sep 29 106 39 16811-6

Download in:

View as

Triples

General Info

PMID
19805378